Venturi Mask Settings for CO₂ Washout
For patients at risk of CO₂ retention requiring controlled oxygen therapy, use a 24% Venturi mask at 2-3 L/min or a 28% Venturi mask at 4 L/min, targeting SpO₂ 88-92%; critically, when the respiratory rate exceeds 30 breaths/min, increase the oxygen flow rate to 50% above the minimum recommended flow to prevent CO₂ rebreathing while maintaining the same FiO₂. 1, 2
Understanding CO₂ Washout with Venturi Masks
Flow Rate Requirements Based on Respiratory Rate
Standard respiratory rates (<30 breaths/min): Use manufacturer-recommended minimum flow rates—24% Venturi at 2-3 L/min delivers total gas flow of 51 L/min; 28% Venturi at 4 L/min delivers 44 L/min total flow 1
Tachypneic patients (>30 breaths/min): Increase oxygen flow to 50% above the minimum specified rate to prevent room air dilution and maintain adequate total gas flow 1, 2
Critical principle: Increasing the oxygen flow rate into a Venturi mask increases the total gas flow from the mask but does not increase the concentration of oxygen delivered 1
Why Flow Rate Matters for CO₂ Washout
The total gas flow generated by the Venturi system must exceed the patient's peak inspiratory flow rate to prevent:
- Room air entrainment that dilutes the prescribed FiO₂ 1, 3
- CO₂ rebreathing from the mask dead space 1
- Increased work of breathing 4
Simple face masks below 5 L/min cause CO₂ rebreathing and increased resistance to inspiration, which is why Venturi masks with their higher total flows are preferred for controlled oxygen delivery 1
Target Oxygen Saturations
Hypercapnic-Risk Patients (COPD, Obesity, Neuromuscular Disease)
- Target SpO₂: 88-92% 1, 5
- Start with 24% Venturi at 2-3 L/min or 28% Venturi at 4 L/min 1, 5
- Alternative: nasal cannula at 1-2 L/min achieves similar range 1
Non-Hypercapnic Patients
- Target SpO₂: 94-98% 1, 5
- Use nasal cannula 2-6 L/min or simple face mask 5-10 L/min as first-line 1, 5
- Escalate to reservoir mask at 15 L/min if SpO₂ remains <85% 1
Mandatory Monitoring Protocol
Arterial Blood Gas Requirements
- Obtain ABG within 30-60 minutes of initiating oxygen therapy in all hypercapnic-risk patients 5
- Repeat ABG 30-60 minutes after any flow rate change 5
- Repeat ABG even if initial PCO₂ was normal, as hypercapnia can develop during admission 5
Blood Gas Interpretation and Action
| Blood Gas Pattern | Action Required | Target SpO₂ |
|---|---|---|
| Normal pH and PCO₂ | May increase target to 94-98% (unless already on NIV/IMV) | 94-98% |
| Raised PCO₂, pH ≥7.35 | Maintain controlled oxygen (chronic compensated) | 88-92% |
| PCO₂ >6 kPa and pH <7.35 | Initiate NIV if acidosis persists >30 min; senior review | 88-92% |
Device Performance Considerations
Venturi Mask Accuracy
- 24% and 28% masks: Deliver FiO₂ within 1.9% of nominal at rest 2
- 60% mask: Delivers approximately 50% FiO₂ (reads low) 2
- Tachypnea effect: Breathing frequency >30/min requires 50% increase in oxygen flow above recommended to maintain accuracy 2
Factors Reducing Delivered FiO₂
- Reinspiration of dead space from the mask (0.2-0.6% CO₂ measured) 2
- Patient's inspiratory flow exceeding mask total flow 1, 6
- Hyperventilation with high tidal volumes 6
- Poor mask fit allowing room air entrainment 1
Critical Safety Points
Never Abruptly Stop Oxygen
- In hypercapnic-risk patients, never abruptly discontinue oxygen—this causes sudden falls in saturation below baseline 5
- Taper gradually using 24% or 28% Venturi mask or nasal cannula 1-2 L/min 5
Escalation Triggers
- SpO₂ remains below target despite appropriate device and flow 5
- Respiratory rate >30 breaths/min persisting after flow adjustment 1
- Development of respiratory acidosis (pH <7.35, PCO₂ >6 kPa) 5
- National Early Warning Score ≥7 5
When to Consider NIV
- PCO₂ >6 kPa with pH <7.35 persisting >30 minutes after standard oxygen therapy 5
- Increasing oxygen requirements despite controlled delivery in hypercapnic-risk patients 5
- Senior medical assessment required before escalating hypercapnic-risk patients to reservoir mask 5
Alternative to Venturi Masks
High-flow nasal cannula (HFNC) should be considered for acute hypoxemic respiratory failure without hypercapnia risk, as it provides heated, humidified oxygen at high flow rates that improve oxygenation and reduce work of breathing 7